Immune regulation by CD40 and its ligand GP39

被引:547
|
作者
Foy, TM
Aruffo, A
Bajorath, J
Buhlmann, JE
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,BIOCHEM GRAD PROGRAM,LEBANON,NH 03756
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
CD40; CD40L; gp39; structure; peripheral tolerance; central tolerance;
D O I
10.1146/annurev.immunol.14.1.591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past three years, CD40 and its ligand (gp39, CD40L, TBAM) have been shown to be essential for humoral immune responses to thymus-dependent antigens. However, as the tissue distribution widens for those cells that express CD40 and gp39, we can now show that this ligand-receptor pair also plays an important role in the selection of self-reactive T cells in the thymus (central tolerance) and the regulation of tolerance in mature T cells (peripheral tolerance). Advances in our understanding of the molecular basis for CD40 biology is based in two areas of research. First, a major breakthrough in our understanding of how CD40 transduces biological events centers on the identification of a novel protein that binds to the cytoplasmic tail of CD40 and may act as a signal transducing molecule. Secondly, advances in molecular modeling and mutagenesis of this ligand-receptor pair have helped to identify the critical receptor/ligand contacts in the gp39/CD40 complex. Advances in each of these areas are discussed.
引用
收藏
页码:591 / 617
页数:27
相关论文
共 50 条
  • [31] Growth inhibition of human multiple myeloma cells by the CD40 ligand GP39.
    Tong, AW
    Seamour, BK
    Ordonez, G
    Stone, MJ
    BLOOD, 1995, 86 (10) : 225 - 225
  • [32] Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice
    Resetkova, E
    Kawai, K
    Enomoto, T
    Arreaza, G
    Togun, R
    Foy, TM
    Noelle, RJ
    Volpe, R
    THYROID, 1996, 6 (04) : 267 - 273
  • [33] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [34] CD40 and its ligand in autoimmunity
    Noelle, RJ
    Mackey, M
    Foy, T
    Buhlmann, J
    Burns, C
    B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 384 - 391
  • [35] CD40 and its ligand in atherosclerosis
    Lutgens, Esther
    Lievens, Dirk
    Beckers, Linda
    Donners, Marjo
    Daemen, Mat
    TRENDS IN CARDIOVASCULAR MEDICINE, 2007, 17 (04) : 118 - 123
  • [36] The CD40 ligand - At the center of the immune universe?
    Grewal, IS
    Flavell, RA
    IMMUNOLOGIC RESEARCH, 1997, 16 (01) : 59 - 70
  • [37] SIGNALING VIA MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES AND ANTIGEN RECEPTORS ENHANCES THE B-CELL RESPONSE TO GP39/CD40 LIGAND
    BISHOP, GA
    WARREN, WD
    BERTON, MT
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) : 1230 - 1238
  • [38] CD40 ligand regulation in megakaryocytes and platelets
    Crist, SA
    Sprague, DL
    Lentz, S
    Ratliff, TL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E72 - E72
  • [39] CD40 LIGAND CD40 DEFICIENCY
    CASTIGLI, E
    FULEIHAN, R
    RAMESH, N
    TSITSIKOV, E
    TSYTSYKOVA, A
    GEHA, RS
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 37 - 39
  • [40] Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA
    Aisha Siddiqa
    Jennifer C. Sims-Mourtada
    Liliana Guzman-Rojas
    Roberto Rangel
    Christiane Guret
    Vicente Madrid-Marina
    Yan Sun
    Hector Martinez-Valdez
    Nature, 2001, 410 : 383 - 387